Rohan J. Hoare

St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN.

LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX.

EndoStim, Inc. develops electro medical devices to treat gastrointestinal neuromuscular disorders. The firm focuses on the development and commercialization of a novel neurostimulation system for the treatment of severe Gastro-esophageal Reflux Disease, commonly known as acid reflux, through electrical stimulation. The company was founded by Bevil J. Hogg, Raul E. Perez and Virendra K. Sharma on June 3, 2009 and is headquartered in Dallas, TX.

Salient Medical Solutions, Inc. provides aesthetic, skin science and ophthalmic solutions. It also provides in-house technical support and technology education, marketing plans and medical practice business development models for their clients, tailoring each program to suit individual requirements. The company is headquartered in Toronto, Canada.

Epi-Minder Pty Ltd. is an Australian company that aims to provide more freedom to people suffering from epilepsy. The company's mission is to improve treatment using previously unseen data. The company has developed the Minder® system, which is currently under evaluation, to reveal unseen epileptic episodes and give clinicians crucial data to improve treatment. The system aims to provide more predictability, seeing data in real-time, knowing what is happening, and sharing that data with clinicians and physicians for greater collaboration on treatment. The company believes that these emotions lead to more episodes, which is why their solution must provide more comfort and confidence. The company's ultimate goal is to forecast seizure-free zones to enjoy more freedom. The CEO of the company is Rohan J. Hoare.